HYDROCHLOROTHIAZIDE W/ HYDRALAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Hydrochlorothiazide W/ Hydralazine patents expire, and when can generic versions of Hydrochlorothiazide W/ Hydralazine launch?
Hydrochlorothiazide W/ Hydralazine is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in HYDROCHLOROTHIAZIDE W/ HYDRALAZINE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE?
- What are the global sales for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE?
- What is Average Wholesale Price for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE?
Summary for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 3 |
| DailyMed Link: | HYDROCHLOROTHIAZIDE W/ HYDRALAZINE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | Phase 4 |
| National Center for Research Resources (NCRR) | Phase 4 |
| Vanderbilt University Medical Center | Phase 1 |
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE W/ HYDRALAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | HYDROCHLOROTHIAZIDE W/ HYDRALAZINE | hydralazine hydrochloride; hydrochlorothiazide | TABLET;ORAL | 085373-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
